Eric Deutsch and Roger Sun Radiation oncology department UMR1030 (with Inserm and Paris-Saclay university) at Gustave Roussy, France
Join at Microsoft Team / Meeting ID: 376 666 385 029 / Passcode: bFR2YD
This lecture will present the latest advancements in translational research that are guiding the combination of radiotherapy and immunotherapy, paving the way for more precise cancer treatments. It will cover emerging technologies and approaches that enable more effective, personalized therapies.
Key topics to be discussed include:
Non-invasive biomarkers: The role of radiomics in optimizing and guiding radiotherapy for individual patie nts.
Microbiota modulation: Understanding how radiotherapy can influence the gut microbiome and patient response to radio-immunotherapy.
Innovative irradiation techniques such as partial irradiation, heterogeneous irradiation, and FLASH therapy